| WestConn scholarship honors Dr. Mel |
|
|
| Written by JBaileyAdmin | |
| Tuesday, 25 September 2007 | |
|
The Danbury News Times gave Dr. Mel and the scholarship in his name a nice write-up this past Sunday. Here's a bit of what Robert Miller wrote:
For 26 years, Goldstein was the head of the meteorology department at Western Connecticut State University in Danbury. But to say he was the head is an understatement. In fact, he created it. |
| < Prev | Next > |
|---|
Multiple Myeloma News Update
-
Push to Cure Rare Diseases
Wall Street Journal
Revlimid (capsules): Treats multiple myeloma, a blood cancer; about 14600 new cases diagnosed every year. Xenazine: Treats chorea, the involuntary muscle ...
and more » -

RTT NewsFacet Biotech Stock Soars on Abbott Bid
TheStreet.com
Facet's oncology collaborations include early- and mid-stage compounds that are being studied to treat different types of cancer, including multiple myeloma ...
BREAKING NEWS: Abbott buys Facet Biotech for $450MFierceBiotech
all 195 news articles » -

ModernMedicineFocal Lesions Found to Predict Multiple Myeloma Progression Related study ...
ModernMedicine
In a related study in the same issue, researchers report that survival after treatment for multiple myeloma decreases with age. Heinz Ludwig, MD, from the ... -
ImmunoGen, Inc. Announces Orphan Drug Designation Granted to IMGN901 for ...
MarketWatch (press release)
CD56 also is expressed on multiple myeloma and certain other hematological malignancies. IMGN901 is in early clinical testing for the treatment of CD56+ ...
and more » -
Myeloma Support Group
WEAU-TV 13
This support group is intended for patients, caregivers and family members involved with or interested in multiple myeloma. ...
and more » -

Seattle Post IntelligencerWhy some couldn't die on their own terms
Seattle Times
Bill Morris, who had multiple myeloma, found a path filled with obstacles as he tried to use the law. Patrick Sullivan of Sequim ...
The Oregonian's picks from popular Northwest news sourcesOregonLive.com (blog)
all 161 news articles » -
Study Points To Age As Significant Risk Factor For Survival In Myeloma Patients
The Myeloma Beacon
The survival time of a multiple myeloma patient is strongly dependent on the patient's age at diagnosis, according to a recent study published in the ... -
International Effort Updates Results From Multiple Myeloma Stem Cell ...
The Myeloma Beacon
A recent paper published in the Journal of Clinical Oncology updated the outcomes of multiple myeloma trials conducted by the Intergroupe Francophone du ...












